Are European universities failing to report clinical trial data in a timely manner?
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
CBI’s 8th Annual Publication and Clinical Trial Transparency Europe
Join CBI for the latest updates on data sharing, collaborating with patients and innovations in publishing.
Five essential factors for data sharing
Discover the five areas for improvement identified in Springer Nature’s recent surveys of researchers, aiming to promote data sharing.
Are ‘funding body journals’ the future of scientific publishing?
A recent article from The Chronicle of Higher Education discusses the potential benefits associated with journals that are established by funding bodies.
Disparities claimed between stance and action on clinical trial outcome reporting by top medical journals
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
It’s time to increase awareness of data ‘FAIRness’
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
Self-citation by peer reviewers: when is it appropriate and how to safeguard against malpractice
Authors and editors are asked to be vigilant, and advice to peer reviewers is updated, amidst scandal of reviewer who asked for multiple self-citations during reviews.
Can holding institution heads to account lead to improved rates of clinical trial reporting?
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Consolidation and regulation is driving the current state of scholarly communications
A recent blog for The Scholarly Kitchen suggests mergers, acquisitions, and new regulations are increasingly changing the state of scholarly communications.
Open peer review: pilot studies reveal promising findings
As an increasing number of journals pilot transparent peer review, data indicate that open peer review does not compromise the process – at least when reviewers can stay anonymous.
Are we delivering on transparency and reproducibility?
Transparency and reproducibility are now synonymous with medical publications, but actions speak louder than words. A recent study examines whether progress has been made.
Building trust with transparency: the importance of financial disclosures in medical publishing
Find out why financial relationships are not always correctly disclosed and how better transparency could be achieved.
The latest updates to ICMJE’s reporting recommendations
The ICMJE recently updated its recommendations, providing guidance on issues such as use of preprint servers, conflict of interest reporting and journal metrics.
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
The global impact of the Medical Writer Joint Position Statement
The impact of the AMWA–EMWA–ISMPP Joint Position Statement on the Role of Professional Medical Writers is revealed in the MAP newsletter.
How to overcome the issue of poorly reported clinical trial outcomes
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.